These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36496061)

  • 1. Differential effect of basal vitamin D status in monocrotaline induced pulmonary arterial hypertension in normal and vitamin D deficient rats: Possible involvement of eNOS/TGF-β/α-SMA signaling pathways.
    Shah S; Vishwakarma VK; Arava SK; Mridha AR; Yadav RK; Seth S; Bhatia J; Hote MP; Arya DS; Yadav HN
    J Nutr Biochem; 2023 Mar; 113():109246. PubMed ID: 36496061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
    Sahara M; Sata M; Morita T; Hirata Y; Nagai R
    PLoS One; 2012; 7(3):e33367. PubMed ID: 22479390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Benidipine Alone and in Combination With Bosentan and Sildenafil in Amelioration of Pulmonary Arterial Hypertension in Experimental Model in Rats.
    Kumari K; Vishwakarma VK; Kumar K; Mridha AR; Arava SK; Dhingra S; Singh N; Yadav HN
    J Cardiovasc Pharmacol; 2024 Apr; 83(4):330-339. PubMed ID: 38241693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
    Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
    Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
    J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats.
    Kanno S; Wu YJ; Lee PC; Billiar TR; Ho C
    Circulation; 2001 Aug; 104(8):945-50. PubMed ID: 11514384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
    Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
    Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
    Nie X; Wu Z; Shang J; Zhu L; Liu Y; Qi Y
    Eur J Pharmacol; 2023 Mar; 943():175546. PubMed ID: 36706802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats by activating PI3K/Akt/eNOS signaling.
    Zheng Z; Yu S; Zhang W; Peng Y; Pu M; Kang T; Zeng J; Yu Y; Li G
    Histol Histopathol; 2017 Jan; 32(1):35-41. PubMed ID: 27087006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosapentaenoic acid ameliorates pulmonary hypertension via inhibition of tyrosine kinase Fyn.
    Kurahara LH; Hiraishi K; Yamamura A; Zhang Y; Abe K; Yahiro E; Aoki M; Koga K; Yokomise H; Go T; Ishikawa K; Bo Z; Kishi H; Kobayashi S; Aoki-Shoi N; Toru S; Inoue R; Hirano K
    J Mol Cell Cardiol; 2020 Nov; 148():50-62. PubMed ID: 32889002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Li Q; Wang J; Zhu X; Zeng Z; Wu X; Xu Y; Xie J; Yu J
    Biomed Pharmacother; 2017 Dec; 96():825-833. PubMed ID: 29078260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saluisn-β contributes to endothelial dysfunction in monocrotaline-induced pulmonary arterial hypertensive rats.
    Pan Y; Chen A; Wang X; Bao C; Liang S; Tang H; Han Y
    Biomed Pharmacother; 2022 Nov; 155():113748. PubMed ID: 36174379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W
    BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats.
    Zheng C; Wang L; Li R; Ma B; Tu L; Xu X; Dackor RT; Zeldin DC; Wang DW
    Am J Respir Cell Mol Biol; 2010 Dec; 43(6):740-9. PubMed ID: 20118222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1.
    Zhao H; Wang Y; Zhang X; Guo Y; Wang X
    Toxicol Appl Pharmacol; 2020 Jan; 386():114827. PubMed ID: 31734320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
    Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
    J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL; Guan RJ; Xu QH; Wu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV blocks monocrotaline‑induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling.
    Jin H; Jiao Y; Guo L; Ma Y; Zhao R; Li X; Shen L; Zhou Z; Kim SC; Liu J
    Int J Mol Med; 2021 Feb; 47(2):595-606. PubMed ID: 33416126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.